Sign in
Active, not recruitingNo phase

Timing of Endoscopy in Cirrhotic Patients With Acute Variceal Bleeding

Key facts

Who runs it
General Hospital of Shenyang Military Region
Where
China1 site in 1 countryChoose a country to see its sites
Trial code
Status
Active, not recruiting
People taking part
368 people, planned
Started
4 Sept 2024
Expected to end
Dec 2026
Type of study
Interventional, 2 groupsOne group gets an existing treatment, for comparison.
Treatments tested
  • Endoscopy
Record updated
14 September 2026

Who can take part

Age
18 years and older
Sex
Women and men
Healthy volunteers
Cannot take part
Show the full registry criteria (11)Hide the full registry criteria

Who can take part

  • patients with AUGIB which is highly suspected to be caused by gastroesophageal variceal rupture
  • patients with a diagnosis of liver cirrhosis based on imaging and pathology
  • patients and/or their relatives who sign informed consents
  • patients' age ≥18 years

Who cannot take part

  • patients who have taken anticoagulants or antiplatelet drugs within 2 weeks before admissions, or are diagnosed with severe hematological diseases
  • patients with severe cardiovascular or cerebrovascular diseases or renal injury
  • patients with human immunodeficiency virus or other acquired or congenital immune deficiency diseases
  • patients with mental illness
  • patients who have undergone endoscopy at other hospitals before admissions
  • patients' hemodynamics are unstable after resuscitation
  • pregnancy

Where is this trial?

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

Endoscopy is important for the diagnosis and treatment of acute upper gastrointestinal bleeding (AUGIB), especially acute variceal bleeding (AVB), in patients with liver cirrhosis. However, the optimal timing of endoscopy remains controversial, primarily because the currently available evidence is of poor quality, and the definition of early endoscopy is also very heterogeneous among studies. Herein, a multicenter randomized controlled trial (RCT) is performed to explore the impact of timing of endoscopy on the outcomes of cirrhotic patients with AVB.

The 2 groups in the trial

  • Early endoscopy groupTreatment being tested

    Intervention of endoscopy is within 12 hours after admission

    Treatment: Endoscopy

  • Delayed endoscopy groupExisting treatment, for comparison

    Intervention of endoscopy is within 12-24 hours after admission

    Treatment: Endoscopy

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Publications
Record updated
14 September 2026